抗NMDA受容体脳炎の急性精神病症状
Tatiana Mengistu1, Anuj Subedi2, Uchenna Unamba2
1Ross University School of Medicine Miramar Florida USA.
Clinical case reports
|February 5, 2026
まとめ
抗NMDA受容体脳炎は、精神症状および神経学的衰弱を呈する若年成人に見られることがある。腫瘍が存在しなくても、早期診断と免疫療法が回復のために不可欠である。
科学分野:
- 神経学
- 免疫学
- 精神医学
背景:
- 抗N-メチル-D-アスパラギン酸(NMDA)受容体脳炎は自己免疫疾患である。
- しばしば神経精神症状および神経学的欠損を呈する。
研究 の 目的:
- 特定の症候群を持つ若年成人における抗NMDA受容体脳炎を考慮することの重要性を強調する。
- 早期診断と治療の必要性を強調する。
主な方法:
- 急性精神症状、神経学的衰弱、緊張病、自律神経不安定症を呈する若年成人の症例レビュー。
- 神経学的検査および可能性のある抗体検査を含む診断ワークアップ。
- 免疫療法による治療。
主要な成果:
- この症状群を呈する患者は抗NMDA受容体脳炎である可能性がある。
- 腫瘍が検出されなくても、診断を除外することはできない。
- 特定された症例では、迅速な免疫療法が良好な神経学的回復につながった。
結論:
- 急性精神症状および急速な神経学的悪化を呈する若年成人においては、抗NMDA受容体脳炎を疑うべきである。
- 良好な神経学的転帰を達成するためには、早期の免疫療法が不可欠である。
- 関連する腫瘍が存在しない場合でも、この診断は重要である。
関連する概念動画
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
643
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
643
Psychosis: Goals of Pharmacotherapy
539
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
539
Psychosis and Antipsychotic Drugs: Overview
913
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
913
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.0K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.0K
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Receptor-mediated Endocytosis
111.0K
Overview
111.0K


